SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950005-09-000185
Filing Date
2009-04-14
Accepted
2009-04-13 19:45:26
Documents
1
Group Members
ALIX MARDUELALTA BIOPHARMA MANAGEMENT III, LLCALTA BIOPHARMA PARTNERS III GMBH & CO. BETEILIGUNGS KGALTA BIOPHARMA PARTNERS III, L.P.ALTA EMBARCADERO BIOPHARMA PARTNERS III, LLCEDWARD HURWITZEDWARD PENHOETFARAH CHAMPSIJEAN DELEAGE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D p20620sc13d.htm SC 13D 143535
  Complete submission text file 0000950005-09-000185.txt   145966
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81034 | Film No.: 09747499
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 4153624022
ALTA BIOPHARMA PARTNERS III LP (Filed by) CIK: 0001257444 (see all company filings)

IRS No.: 050573803 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D